International Clinical Trial: Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07457541) titled 'Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI' on March 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences

Condition: Lung Cancer (Locally Advanced or Metastatic) Pancreas Cancer, Metastatic Breast Cancer (Locally Advanced or Metastatic) Colorectal Cancer (Locally Advanced or Metastatic)

Intervention: Drug: [99mTc]Tc-HYNIC-FAPI

Recruitment Status: Not rec...